IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4. [electronic resource]
Producer: 20130814Description: 59-64 p. digitalISSN:- 1365-2893
- Adult
- Antiviral Agents -- administration & dosage
- Drug Therapy, Combination
- Female
- Gene Frequency
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- administration & dosage
- Interferons
- Interleukins -- genetics
- Logistic Models
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Polymorphism, Single Nucleotide
- RNA, Viral -- genetics
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Syria
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.